Elbasateeny et al. found that CD44 expression tended to decrease with increasing aggressiveness and progression of EC, and downregulation of CD44 may suggest a more aggressive process and may be associated with carcinosarcomas with poor prognosis [53]. Here, CD44 is linked to carcinosarcoma.